After initially downplaying the severity of a measles outbreak in Texas, U.S. Health Secretary Robert F. Kennedy Jr. has now shifted his stance, calling it a top priority for his department. His reversal follows the death of an unvaccinated child, marking the first measles-related fatality in the U.S. in a decade.
Kennedy, who has a history of questioning vaccines, acknowledged the outbreak in a post on X, saying his team is working to contain the spread. As part of the federal response, the Department of Health and Human Services (HHS) is supplying Texas with 2,000 doses of the measles, mumps, and rubella (MMR) vaccine. The vaccine is typically given to children in two doses—one at 12 to 15 months and another between ages four and six—to provide full protection.
The U.S. Centers for Disease Control and Prevention (CDC) has reiterated that vaccines are the most effective safeguard against measles, a highly contagious disease. Since late January, Texas has reported more than 140 cases, with nearly 20 people hospitalized. Nationwide, 164 cases have been confirmed across multiple states, including California, Georgia, Kentucky, and New York City. CDC data indicates that 95% of those infected were unvaccinated, while another 3% had received only one of the two recommended doses. The outbreak has surged nearly 80% in the past week.
Kennedy’s handling of the crisis has sparked renewed scrutiny over his vaccine views. As the founder of an anti-vaccine advocacy group, he has long cast doubt on vaccine safety. However, he insists he is not against vaccines and has stated that he would not prevent Americans from choosing immunization.
In a separate development, Kennedy’s HHS department announced a policy shift that would reduce public participation in the agency’s decision-making process. This move contradicts his earlier pledge of transparency when he was confirmed to the position. For decades, the HHS has allowed public input on policies affecting healthcare regulations, vaccines, and programs like Medicare and Medicaid. Critics argue that limiting public engagement could significantly impact future health policies.
Kennedy has yet to respond to the backlash over the proposed changes.